Latest news
RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 07:28:07 GMTFDA Clears IND for RiboX’s RXIM002, Circular RNA CAR-T for ITP - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 06:34:09 GMTHaze leaves six Sarawak areas with unhealthy air quality - The Malaysian ReserveThe Malaysian Reserve · Sat, 08 Aug 2026 09:57:26 GMTRiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias - The Manila TimesThe Manila Times · Sat, 08 Aug 2026 08:04:32 GMT